Comparative Performance of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes
Researchers compared the beneficial effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors on gout risk in patients with type 2 diabetes.
All articles by Rheumatology Advisor Contributing Writer
Updated EULAR/ERA-EDTA Recommendations for the Management of Lupus Nephritis
The EULAR/ERA-EDTA developed updated recommendations for the management of lupus nephritis.
Education and Better Physician Interaction May Improve Management of Gout
Researchers sought to understand the unmet needs for patients and provide insight into achieving better treatment for gout.
Serum Urate-Associated Genetic Variants Strongly Contribute to Gout Risk Regardless of Diuretic Use
Researchers determined the effect of serum urate-associated genetic variants on gout risk in individuals receiving diuretics vs those who were not.
Treat-to-Target Approach May Improve Renal Function in Patients With Gout and Chronic Kidney Disease
Researchers assessed changes in the estimated glomerular filtration rate among patients with gout with moderate renal impairment, using a treat-to-target approach for gout.
Remission Criteria Validated, New Criteria Defined for Complete Response in Chronic Refractory Gout
Researchers assessed the criteria for gout remission and defined the criteria for a complete response in patients with chronic refractory gout.
Fewer Side Effects With Naproxen vs Low-Dose Colchicine in Gout Flare Treatment
Researchers compared the effectiveness and safety of naproxen with low-dose colchicine in the treatment of gout flares in primary care.
Lower Risk for Gout With SGLT2 Inhibitors vs GLP1 Agonists in Type 2 Diabetes
Researchers assessed the risk for gout among adults receiving a sodium-glucose cotransporter 2 inhibitor vs a glucagon-like peptide-1 receptor agonist.
Biopsy-Informed Management Safely, Accurately Predicts Flares in Lupus Nephritis
This study reports the long-term renal outcomes of kidney biopsies performed at prespecified intervals to determine the safety and accuracy of tapering of maintenance immunosuppression.
Gout Risk During Tuberculosis Treatment Higher With Obesity, Chronic Kidney Disease, Hyperuricemia
Researchers investigated the clinical features and risk factors for gout during tuberculosis treatment in a South Korean population.
-
Loading...
-
Loading...
Next post in Hyperuricemia
